(ADXS:Consolidated Issue listed on NASDAQ Capital Market)
Earnings & Estimates Summary - ADVAXIS INC (ADXS)
2013 revenues at Advaxis, Inc. totaled $0.0 USD, while annual losses equaled $4.10 per share.
Quarterly Earnings & Estimates - ADVAXIS INC (ADXS)
Advaxis, Inc.'s Quarterly Earnings
Advaxis, Inc. reported 2nd quarter 2014 losses of $0.15 per share on 06/12/2014.
Annual Earnings & Estimates - ADVAXIS INC (ADXS)
Advaxis, Inc.'s Annual Earnings
Advaxis, Inc. reported annual 2013 losses of $4.10 per share on 01/31/2014.
Quarterly Revenues - ADVAXIS INC (ADXS)
Annual Revenues - ADVAXIS INC (ADXS)
Advaxis, Inc.'s Annual Revenues
Advaxis, Inc. did not report revenues for the full year 2013. However, during the prior year the company reported revenues of $0.0 USD.
|Eurocine Vaccines AB||kr1.98 SEK||-0.11|
|Genocea Biosciences Inc||$12.21 USD||-0.06|
|GenVec Inc||$2.51 USD||+0.03|
|ZIOPHARM Oncology Inc||$8.99 USD||+0.32|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|